An prospective, single center, open, stage II clinical trail of Apatinib for treatment of locally advanced or metastatic thyroid undifferentiated thyroid cancer
Latest Information Update: 19 Sep 2017
At a glance
- Drugs Rivoceranib (Primary)
- Indications Thyroid cancer
- Focus Therapeutic Use
- 19 Sep 2017 New trial record